story of the week
Clinical Consequences of Chemotherapy Dose Reduction in Obese Patients With Stage III Colon Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
European Journal of Cancer
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Clinical Consequences of Chemotherapy Dose Reduction in Obese Patients With Stage III Colon Cancer: A Retrospective Analysis From the PETACC 3 Study
Eur. J. Cancer 2018 Aug 01;99(xx)49-57, G Stocker, UT Hacker, F Fiteni, J John Mahachie, AD Roth, E Van Cutsem, M Peeters, F Lordick, M MauerFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.